Elixir Pharmaceuticals is a biotech company focused on developing treatments to combat ageing and age-related diseases by targeting the biological mechanisms of ageing. Founded with insights from leading researchers in ageing science, Elixir aimed to translate cutting-edge research into practical therapies.

A key focus of the company is sirtuins, a family of enzymes believed to influence ageing processes and lifespan by regulating cellular stress responses and metabolic functions. By exploring these pathways, Elixir sought to develop drugs that could mimic the effects of caloric restriction, a well-documented method for extending lifespan in various organisms.